Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Anti-NKG2A antibodies

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Anti-NKG2A antibodies are emerging as a promising class of immune checkpoint inhibitors in cancer immunotherapy.. These antibodies target the NKG2A receptor

Anti-NKG2A antibodies work by:

Restoring and enhancing the cytotoxic activity of NK cells and T cells against tumor cells

Immune Checkpoint Inhibitors: Anti-NKG2A Antibodies on Board
Mingari et al. 2019 Trends in Immunology 40: 83

7/1/2026